What the research found

GLP-1 and GLP-1/GIP medications suppress appetite and produce meaningful weight loss, but the composition of that loss matters. Across trials, lean tissue (including muscle) accounts for roughly 25–45% of total weight shed, depending on the drug—semaglutide trends higher, tirzepatide lower. A landmark trial showed that when people combined resistance training with adequate protein during GLP-1 therapy, they preserved or even gained lean mass despite being in a caloric deficit, whereas medication alone allowed more muscle to be lost alongside the fat.

The pattern reverses when people stop the medication. In one year-long follow-up, individuals who had maintained an exercise habit during treatment kept their weight and body composition stable after stopping, while those relying on medication alone without building exercise habits regained weight—mostly as fat. Bone mineral density also declined over a year of GLP-1 therapy without exercise, but remained stable when training was added.

Why it matters for you

If you're using a GLP-1 to lose weight, the scale tells only half the story. Losing 20 kg of which 9 kg is muscle is metabolically different from losing 20 kg of which 5 kg is muscle. Muscle drives your resting metabolic rate; less of it means your body burns fewer calories at rest. For women navigating perimenopause or menopause—when hormonal shifts already accelerate muscle loss—this compounds the problem.

The solution is structural, not pharmacological. Resistance training 3–4 times per week, focused on compound movements with progressive overload, signals your body to retain muscle during a deficit. Protein intake matters equally; spreading 0.6 g per pound of body weight across the day (especially at breakfast, when GLP-1 tends to suppress appetite most) gives muscle the substrate to repair. Neither works alone—protein without training doesn't prevent lean mass loss, and training without protein underperforms.

This matters for long-term outcomes too. If you taper your GLP-1 or stop altogether, the habits you build now—lifting, consistent protein—are what sustain your weight and body composition. One trial showed people who maintained exercise after stopping the medication kept their results; those who didn't regained. Think of your training and nutrition now as an investment in your metabolic health and independence a year or two from now.

Caveats

• Most mechanistic work cited is from small, short-duration trials (weeks to months) often in men or younger populations; extrapolation to women in midlife is inferential
• The one trial following people post-GLP-1 discontinuation was relatively small; larger, longer studies are needed to confirm the durability of exercise-built habits
• Bone mineral density decline on GLP-1 alone has been observed but the clinical significance (fracture risk, long-term trajectory) remains unclear
• Protein requirements on GLP-1 are inferred partly from general resistance training guidelines, not GLP-1-specific trials
• Studies on exercise + GLP-1 used lower-intensity protocols (intervals, circuits); evidence for barbell-based training specifically in this context is limited